S5I
Cerdulatinib
Created: | 2022-12-13 |
Last modified: | 2023-12-20 |
Find Related PDB Entry |
---|
Find related ligands: |
---|
Chemical Details | |
---|---|
Formal Charge | 0 |
Atom Count | 58 |
Chiral Atom Count | 0 |
Bond Count | 61 |
Aromatic Bond Count | 12 |
Chemical Component Summary | |
---|---|
Name | Cerdulatinib |
Synonyms | 4-(cyclopropylamino)-2-[[4-(4-ethylsulfonylpiperazin-1-yl)phenyl]amino]pyrimidine-5-carboxamide |
Systematic Name (OpenEye OEToolkits) | 4-(cyclopropylamino)-2-[[4-(4-ethylsulfonylpiperazin-1-yl)phenyl]amino]pyrimidine-5-carboxamide |
Formula | C20 H27 N7 O3 S |
Molecular Weight | 445.538 |
Type | NON-POLYMER |
Chemical Descriptors | |||
---|---|---|---|
Type | Program | Version | Descriptor |
SMILES | CACTVS | 3.385 | CC[S](=O)(=O)N1CCN(CC1)c2ccc(Nc3ncc(C(N)=O)c(NC4CC4)n3)cc2 |
SMILES | OpenEye OEToolkits | 3.1.0.0 | CCS(=O)(=O)N1CCN(CC1)c2ccc(cc2)Nc3ncc(c(n3)NC4CC4)C(=O)N |
Canonical SMILES | CACTVS | 3.385 | CC[S](=O)(=O)N1CCN(CC1)c2ccc(Nc3ncc(C(N)=O)c(NC4CC4)n3)cc2 |
Canonical SMILES | OpenEye OEToolkits | 3.1.0.0 | CCS(=O)(=O)N1CCN(CC1)c2ccc(cc2)Nc3ncc(c(n3)NC4CC4)C(=O)N |
InChI | InChI | 1.06 | InChI=1S/C20H27N7O3S/c1-2-31(29,30)27-11-9-26(10-12-27)16-7-5-15(6-8-16)24-20-22-13-17(18(21)28)19(25-20)23-14-3-4-14/h5-8,13-14H,2-4,9-12H2,1H3,(H2,21,28)(H2,22,23,24,25) |
InChIKey | InChI | 1.06 | BGLPECHZZQDNCD-UHFFFAOYSA-N |
Drug Info: DrugBank
DrugBank ID | DB15499 |
---|---|
Name | Cerdulatinib |
Groups | investigational |
Description | Cerdulatinib is under investigation in clinical trial NCT04021082 (CELTIC-1: A Phase 2B Study of Cerdulatinib in Patients With Relapsed/refractory Peripheral T-cell Lymphoma (PTCL)). |
Synonyms |
|
Categories | Sulfur Compounds |
CAS number | 1198300-79-6 |
Related Resource References
Resource Name | Reference |
---|---|
Pharos | CHEMBL4116008 |
PubChem | 44595079 |
ChEMBL | CHEMBL4116008 |